Author

Zhihua Xing

Institution: Harbin University of Commerce

Observed institutions: Sichuan University, West China Medical Center of Sichuan University, Harbin University of Commerce, West China Hospital of Sichuan University

ORCID: 0000-0002-9264-3905

Observed ORCID: 0000-0002-9264-3905

OpenAlex ID: A5111918397

Recent progress in topoisomerase inhibitors as anticancer agents: Research and design strategies for Topo I and II inhibitors via structural optimization

2025 · Guanghuan Shen, Shihao Li, et al. · Bioorganic Chemistry · 18

The regulation of gut microbiota and urate lowering: A study on the mechanisms of action of probiotics and plant components

2025 · Zhihua Xing, Yue Xu, et al. · PharmaNutrition · 6

Diverse Development Approaches for Xanthine Oxidase Inhibitors: Synthetic Chemistry, Natural Product Chemistry, and Drug Repositioning

2025 · Zhihua Xing, Wen Jiang, et al. · Current Medicinal Chemistry · 3

Comprehensive research on berry polysaccharides: Extraction, structure, mechanism, structure-activity relationship and application from traditional insight to intelligent prediction

2026 · Zihao Wang, Rui Zhang, et al. · Phytomedicine · 1

A dual-track strategy: multi-target, bidirectional modulation of uric acid biosynthesis and renal elimination by natural products—molecular insights

2026 · Zhihua Xing, Siyu Sun, et al. · Journal of Pharmacy and Pharmacology

Design, synthesis and biological evaluation of novel guanidine-containing matrine derivatives as Topo I/II dual target inhibitors

2026 · Shihao Li, Yu Zhu, et al. · European Journal of Medicinal Chemistry

Effect and Mechanism of Rhein‐Neodymium Complex on Intestinal Uric Acid Excretion in Rats with Renal Injury and Hyperuricemia

2026 · Zhihua Xing, Wen Jiang, et al. · ChemistrySelect

Corrigendum to “The diosgenin prodrug nanoparticles with pH-responsive as a drug delivery system uniquely prevents thrombosis without increased bleeding risk” [Nanomed: Nanotechnol Biol Med (April 2018) volume 14, issue 3, pages 673–684]

2025 · Zeliang Wei, Guang Xin, et al. · Nanomedicine Nanotechnology Biology and Medicine

Design, Synthesis, and Evaluation of Cordycepin Derivatives as Antitumor Agents

2025 · Linlin Cui, Zheng Xu, et al. · Chemistry & Biodiversity

Works count: 9

Citation count: 28

H-index: 3

I10-index: 1